Ashley Cordova, the Chief Executive Officer of $NVCR, bought 81,550 shares of the company on 09-05-2025 for an estimated $996,859. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 22.9%. Following this trade, they now own 437,569 shares of this class of $NVCR stock.
$NVCR Insider Trading Activity
$NVCR insiders have traded $NVCR stock on the open market 16 times in the past 6 months. Of those trades, 4 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $NVCR stock by insiders over the last 6 months:
- ASHLEY CORDOVA (Chief Executive Officer) purchased 81,550 shares for an estimated $996,859
- FRANK X LEONARD (EVP, Pres., Novocure Oncology) has made 0 purchases and 3 sales selling 30,196 shares for an estimated $528,412.
- CHRISTOPH BRACKMANN (Chief Financial Officer) has made 3 purchases buying 20,000 shares for an estimated $231,800 and 0 sales.
- W ANTHONY VERNON sold 999 shares for an estimated $17,329
- TIMOTHY J SCANNELL sold 999 shares for an estimated $17,299
- GABRIEL LEUNG sold 999 shares for an estimated $17,297
- DAVID HUNG sold 999 shares for an estimated $17,279
- ALLYSON J OCEAN sold 999 shares for an estimated $17,269
- KRISTIN STAFFORD sold 999 shares for an estimated $17,258
- JERYL L HILLEMAN sold 999 shares for an estimated $17,246
- MARTIN J. MADDEN sold 999 shares for an estimated $17,175
- MUKUND PARAVASTHU (Chief Operating Officer) sold 592 shares for an estimated $10,604
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NVCR Hedge Fund Activity
We have seen 129 institutional investors add shares of $NVCR stock to their portfolio, and 138 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS removed 8,945,166 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $159,223,954
- SOLEUS CAPITAL MANAGEMENT, L.P. added 1,382,888 shares (+25.0%) to their portfolio in Q2 2025, for an estimated $24,615,406
- CAPITAL WORLD INVESTORS added 1,167,319 shares (+22.4%) to their portfolio in Q2 2025, for an estimated $20,778,278
- BLACKROCK, INC. added 1,086,692 shares (+8.3%) to their portfolio in Q2 2025, for an estimated $19,343,117
- AMERICAN CENTURY COMPANIES INC added 959,079 shares (+1354.7%) to their portfolio in Q2 2025, for an estimated $17,071,606
- DEERFIELD MANAGEMENT COMPANY, L.P. added 825,119 shares (+inf%) to their portfolio in Q2 2025, for an estimated $14,687,118
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 718,055 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,781,379
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NVCR Analyst Ratings
Wall Street analysts have issued reports on $NVCR in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 06/27/2025
To track analyst ratings and price targets for $NVCR, check out Quiver Quantitative's $NVCR forecast page.
$NVCR Price Targets
Multiple analysts have issued price targets for $NVCR recently. We have seen 5 analysts offer price targets for $NVCR in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Larry Biegelsen from Wells Fargo set a target price of $14.5 on 07/25/2025
- Kevin DeGeeter from Ladenburg Thalmann set a target price of $30.0 on 07/08/2025
- Jason Bednar from Piper Sandler set a target price of $34.0 on 06/27/2025
- David Nierengarten from Wedbush set a target price of $27.0 on 04/16/2025
- Jessica Fye from JP Morgan set a target price of $28.0 on 04/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
